Form 4: UHS Exec Peterson Granted 5,627 Restricted Stock Units

Universal Health Services Executive Vice President Matthew Jay Peterson received a grant of 5,627 restricted stock units, vesting over four years.

Summary

• Matthew Jay Peterson, Executive Vice President of Universal Health Services Inc. (UHS), was granted 5,627 shares of Class B Common Stock.
• These shares are restricted stock units (RSUs) awarded under the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan.
• The RSUs will vest ratably on March 26, 2027, March 26, 2028, March 26, 2029, and March 26, 2030.
• Following this transaction, Peterson's total beneficial ownership in UHS is 31,984.2263 shares.
• This total includes 591.2263 shares previously purchased at a discounted rate through the Universal Health Services 2005 Employee Stock Purchase Plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting standard executive compensation practices that align management incentives with long-term shareholder interests, without indicating any immediate operational changes.

Positives

• The grant of restricted stock units aligns management's interests with long-term shareholder value through multi-year vesting.
• Increased insider ownership, even through grants, can signal confidence in the company's future performance.

Future Outlook

The vesting schedule for the restricted stock units extends through March 2030, indicating a long-term incentive structure for the executive.

Industry Context

StockSavvy.ai notes that executive compensation through restricted stock units is a standard practice in the healthcare services industry, aligning executive incentives with long-term company performance and shareholder value creation. This type of grant is common across publicly traded companies, including peers like HCA Healthcare (HCA) and Tenet Healthcare (THC), as a means to retain talent and foster commitment.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) with multi-year vesting is a common compensation practice for executives in large healthcare providers, similar to structures seen at HCA Healthcare, Community Health Systems, and Tenet Healthcare.
• A $0 acquisition price for RSUs is standard, as these are grants of equity compensation rather than open market purchases.
• The four-year ratable vesting schedule is typical for executive equity awards, designed to encourage long-term retention and performance, comparable to vesting schedules observed in companies like CVS Health (which owns Aetna) for its executive team.

Stakeholder Impact

• Shareholders: The grant aligns executive incentives with long-term shareholder value creation, potentially fostering sustained performance.
• Employees: Reflects the company's ongoing use of equity compensation plans, which can be a positive for employee retention and motivation if similar plans are available more broadly.

Next Steps

• The restricted stock units will vest ratably on March 26, 2027, March 26, 2028, March 26, 2029, and March 26, 2030.

Key Dates

Recommendation

This Form 4 filing reports a routine executive compensation event involving a restricted stock unit grant. While it aligns executive incentives with long-term shareholder value, it does not provide new material information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It is a standard disclosure for executive equity awards.

Keywords

Universal Health Services, UHS, Form 4, Insider Trading, Restricted Stock Units, RSU Grant, Executive Compensation, Stock Plan, Matthew Jay Peterson